https://www.giampharma.com/en/fraisinib-a-calixpyrrole-derivative-reducing-a549-cell-derived-nsclc-tumor-in-vivo-acts-as-a-ligand-of-the-glycine-trna-synthase-a-new-molecular-target-in-oncology-2/2025-06-03T16:33:14+02:00https://www.giampharma.com/en/two-calix4pyrroles-as-potential-therapeutics-for-castration-resistant-prostate-cancer-2/2025-06-03T16:33:27+02:00https://www.giampharma.com/en/a-novel-calix4pyrrole-derivative-as-a-potential-anticancer-agent-that-forms-genotoxic-adducts-with-dna-2/2025-06-03T16:33:08+02:00